Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Amol Pendse"'
Autor:
Sundeep Salvi, Manish K Jain, Srikanth Krishnamurthy, Akash Balki, Rahul Kodgule, Monika Tandon, Sagar Bhagat, Sagar Panchal, Nishtha Khatri, Wen Wu, Amol Pendse, Saiprasad Patil, Hanmant Barkate
Publikováno v:
Lung India, Vol 39, Iss 6, Pp 517-524 (2022)
Background: The safety and efficacy of fixed-dose combination (FDC) of glycopyrronium bromide 12.5 μg/formoterol fumarate 12 μg (GB/FF) twice daily as dry powder inhalers (DPIs) compared to glycopyrronium 50 μg monotherapy (GLY) once daily as DPI
Externí odkaz:
https://doaj.org/article/052dbb819fae4f47a2236abea3e17974
Autor:
Zarir F. Udwadia, Pawan Singh, Hanmant Barkate, Saiprasad Patil, Shabbir Rangwala, Amol Pendse, Jatin Kadam, Wen Wu, Cynthia F. Caracta, Monika Tandon
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss , Pp 62-71 (2021)
Objective: To assess the efficacy and safety of favipiravir in adults with mild-to-moderate coronavirus disease 2019 (COVID-19). Methods: In this randomized, open-label, parallel-arm, multicenter, phase 3 trial, adults (18–75 years) with RT-PCR con
Externí odkaz:
https://doaj.org/article/4e4066fdaf884deba2ec80352ad2f675
Autor:
Sundeep Salvi, Akash Balki, Srikanth Krishnamurthy, Sagar Panchal, Saiprasad Patil, Rahul Kodgule, Hitesh Khandagale, Amol Pendse, Wen Wu, Shabbir Rangwala, Monika Tandon, Hanmant Barkate
Publikováno v:
ERJ Open Research, Vol 7, Iss 3 (2021)
Background The aim of this work was to investigate the safety and efficacy of single-inhaler triple therapy with 12.5 μg glycopyrronium (GB)/12 μg formoterol fumarate (FF)/250 μg fluticasone propionate (FP), compared to 50 μg GB co-administered w
Externí odkaz:
https://doaj.org/article/75c81963141e4675813d77edae65dde4
Autor:
S.R. Aravind, Arthur Asirvatham, Jayashri Shembalkar, Ramesh Goyal, Rajesh Gaikwad, Manoj Chawla, Sivakumar Vaidyanathan, Hemant Thacker, Hanmant Barkate, Rahul R. Kodgule, Sagar Katare, Pradnya Kadam, Brij Mohan, Amol Pendse, Hansraj Alva, S. Paramesh, Monika Tandon, R. Balamurugan, Sachin R. Suryawanshi, Mala Dharmalingam
Publikováno v:
Drugs
Background Metformin is the first-line treatment for type 2 diabetes mellitus (T2DM), but many patients either cannot tolerate it or cannot achieve glycemic control with metformin alone, so treatment with other glucose-lowering agents in combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::531ef2d717c9f66e0e5be4907b7facbf
http://europepmc.org/articles/PMC7165159
http://europepmc.org/articles/PMC7165159
Autor:
Monika Tandon, Rahul Ramesh Kodgule, Keith Moore, Stephen Winchester, Yuan-Po Tu, Chris Miller, Wen Wu, Amol Pendse, Shabbir Rangwala, Shashank R Joshi
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d30179254a0d0ef98a12840394e6f4a
https://doi.org/10.2139/ssrn.4063814
https://doi.org/10.2139/ssrn.4063814
Autor:
Monika Tandon, Wen Wu, Keith Moore, Stephen Winchester, Yuan-Po Tu, Christopher Miller, Rahul Kodgule, Amol Pendse, Shabbir Rangwala, Shashank Joshi
Publikováno v:
The Lancet Regional Health - Southeast Asia. 7:100110
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55e8a614c456b98640422810ba166efa
https://doi.org/10.1016/j.lansea.2022.100110
https://doi.org/10.1016/j.lansea.2022.100110
Autor:
Saiprasad Patil, Hanmant Barkate, Shabbir Rangwala, Srikanth Krishnamurthy, Sagar Panchal, Amol Pendse, Wen Wu, Monika Tandon, Rahul Kodgule, Hitesh Khandagale, Akash Balki, Sundeep Salvi
Publikováno v:
ERJ Open Research, Vol 7, Iss 3 (2021)
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research
article-version (VoR) Version of Record
Background The aim of this work was to investigate the safety and efficacy of single-inhaler triple therapy with 12.5 μg glycopyrronium (GB)/12 μg formoterol fumarate (FF)/250 μg fluticasone propionate (FP), compared to 50 μg GB co-administered w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44612416c93b415845064f16638f3465
http://openres.ersjournals.com/content/7/3/00255-2021.full
http://openres.ersjournals.com/content/7/3/00255-2021.full
Autor:
Shabbir Rangwala, Hanmant Barkate, Pawan Singh, Jatin Kadam, Zarir F. Udwadia, Amol Pendse, Cynthia F. Caracta, Wen Wu, Monika Tandon, Saiprasad Patil
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 103, Iss, Pp 62-71 (2021)
International Journal of Infectious Diseases, Vol 103, Iss, Pp 62-71 (2021)
Highlights • Favipiravir is an oral RNA-dependent RNA polymerase inhibitor. • Favipiravir is under investigation in many countries for treatment of COVID-19. • We evaluated favipiravir’s efficacy and safety in mild-to-moderate COVID-19. • F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7853c0f3b810cae39a30815cf5cc6d07
http://europepmc.org/articles/PMC7668212
http://europepmc.org/articles/PMC7668212
Autor:
Nishtha Khatri, Sundeep Salvi, ManishK Jain, Srikanth Krishnamurthy, Akash Balki, Rahul Kodgule, Monika Tandon, Sagar Bhagat, Sagar Panchal, Wen Wu, Amol Pendse, Saiprasad Patil, Hanmant Barkate
Publikováno v:
Lung India. 39:517
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca5fa3a7caf8b0dce4de8d24ea073851
https://doi.org/10.4103/lungindia.lungindia_136_22
https://doi.org/10.4103/lungindia.lungindia_136_22